Related Experiment Video
Updated: May 9, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study
Zaineb H Makhzoumi1, Sarah T Arron
1Department of Dermatology, University of California, Dermatologic Surgery and Laser Center, San Francisco, California 94143, USA.
Abstract:
Robinson et al. report a population-based case-control study to examine the association between a history of photosensitizing medication use and non-melanoma skin cancer. They report an increased risk of basal cell carcinoma with tetracycline use and of squamous cell carcinoma with diuretic use. Appropriate counseling regarding sun exposure may reduce skin cancer in patients exposed to these medications.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Cancer Prevention
Some...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutagenicity and Carcinogenicity
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
